Summary
Intraperitoneal infusion of insulin should be more physiological than intravenous insulin since part of the insulin is directed toward the portal vein, which allows the liver to retain its major role in glucose homeostasis. The regulation of hepatic glucose production during the intraperitoneal and intravenous infusions of insulin were compared in eight Type 1 (insulin-dependent), C-peptide-deficient diabetic patients. Primed, continuous infusions of [6,6-2H] glucose were given in the postabsorptive state and during continuous infusion of unlabelled glucose at 1.5 and 4 mg/kg· min, while normoglycaemia was maintained by closed-loop intraperitoneal and intravenous insulin delivery. During all three periods, plasma glucose concentrations remained near normal (variations 3.8–6.1%). The insulin infusion rates required for normal plasma glucose concentrations were essentially the same for the intravenous and intraperitoneal routes in all cases, although the variations were greater with intraperitoneal insulin. Plasma free-insulin levels were only slightly, non-significantly lower with intraperitoneal infusion than with intravenous infusion. Hepatic glucose production was significantly lower with intraperitoneal insulin during all three conditions: basal: 1.71±0.14, i.p. vs 2.37±0.26 mg/kg · min, i.v.; 1.5 mg/kg · min glucose infusion: 0.49±0.23, i.p. vs 0.88±0.18 mg/kg · min, i.v.; 4 mg/kg · min glucose infusion: 0.31±0.10, i.p. vs 0.56±0.12 mg/kg · min, i.v. These results, obtained with steady-state conditions for plasma glucose, isotopic plasma glucose enrichments and unlabelled glucose infusion rates, suggest that better control of hepatic glucose production leading to normoglycaemia was achieved with the intraperitoneal infusion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Selam JL, Slingeneyer A, Hedon B, Mares P, Beraud JJ, Mirouze J (1983) Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes. Diabetes Care 6: 105–111
Irsigler K, Kritz H, Hagmuller G et al. (1981) Long-term continuous intraperitoneal insulin infusion with an implanted remotecontrolled insulin infusion device. Diabetes 30: 1072–1075
Selam JL, Charles MA (1990) Devices for insulin administration. Diabetes Care 13: 955–979
Schade DS, Eaton RP, Davis T et al. (1981) The kinetics of peritoneal insulin absorption. Metabolism 30: 149–155
Nelson JA, Stephen R, Landou ST, Wilson DE, Tyler FH (1982) Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized unrestrained swine. Metabolism 31: 969–972
Radziuk J, Pye S, Davies G, Seigler D, Reeves M (1988) Splanchnic and systemic absorption of intraperitoneal insulin. Diabetes Res Clin Pract 5 [Suppl 1]: 24A (Abstract)
Selam JL, Bergman RN, Raccah D, Jean-Didier N, Lozano J, Charles MA (1990) Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes 39: 1361–1365
Felig P, Wahren J (1971) Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man. J Clin Invst 50: 1702–1711
Blackard WG, Nelson NC (1970) Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19: 302–306
Beylot M, Khalfallah Y, Laville M et al. (1987) Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin infusion. Diabete Metab 13: 450–456
Botz CK, Leibel BS, Zingg W, Gander RE, Albisser AM (1976) Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas). Diabetes 25: 691–700
Stevenson RW, Parsons JA, Alberti KGMM (1981) Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs. Metabolism 30: 745–752
Fischer U, Rizza RA, Hall LD et al. (1982) Comparison of peripheral and portal venous insulin administration on postprandial metabolic responses in alloxan-diabetic dogs. Effects of identical preprogrammed complex insulin infusion waveforms. Diabetes 31: 579–584
Stevenson RW, Parsons JA, Alberti KGMM (1983) Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs. Am J Physiol 244: E190–195
Ishida T, Chap Z, Chou J et al. (1984) Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs. Diabetes 33: 984–990
Freyse EJ, Fischer U, Albrecht G, Marx S, Keilacker H (1987) The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs. Diabetologia 30: 402–408
Ader M, Bergman RN (1990) Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258: E1020-E1032
Kryshak EJ, Butker PC, Marsh C et al. (1990) Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery. Diabetes 39: 142–148
Brown J, Mullen Y, Clark WR, Molnar IG, Heininger D (1979) Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases. J Clin Invest 64: 1688–1694
Kruszynska YT, Home PD, Alberti KGMM (1985) Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats. Diabetologia 28: 167–171
Albisser AM, Nomura M, Greenberg GR, McPhedran NT (1986) Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes 35: 97–100
Duckworth WC, Saudeck CD, Henry RR (1992) Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 41: 657–661
Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HLA, Vranic M (1992) Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90: 1769–1777
Shishko PI, Kovalev PA, Goncharov VG, Zajarny IU (1992) Comparison of peripheral and protal (via the umbilical vein) routes of insulin infusion in IDDM patients. Diabetes 41: 1042–1049
Bouanick B, M'Bemba J, Chevalier A, Robert JJ, Slama G, Selam JL (1992) Insulin administered intraperitoneally and intravenously suppress identically hepatic glucose production at matched systemic levels. Diabetologia 35 [Suppl 2]: A37 (Abstract)
Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A (1991) Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45: 13–21
Leblanc H, Chauvet D, Lombrail P, Robert JJ (1986) Glycemic control with closed-loop intraperitoneal insulin in type I diabetes. Diabetes Care 9: 124–128
Wolfe RR, Allsop JR, Burke JF (1979) Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism 28: 210–219
Duncombe WG (1964) The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 9: 122–125
Williamson DH, Mellanby J, Krebs HA (1962) Enzymatic determination of D(-) beta-hydroxybutyric acid and aceto acetic acid in blood. Biochem J 82: 90–95
Kyzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26: 22–29
Kaneko T, Oko H (1974) Radioimmunoassay of human proinsulin and C-peptide using synthetic human connecting peptide. Endocrinol Jpn 21: 141–144
Wiecko J, Sherman WR (1976) Boroacetylation of carbohydrates. Correlations between structure and mass spectral behavior in monoacetylhexose cyclic boronic esters. J Am Chem Soc 98: 7631–7637
Bier DM, Sherman WR, Arnold KJ, Holland WH, Holmes WF, Kipnis DM (1977) Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 26: 1005–1015
Schade DS, Eaton RP (1980) The peritoneum. A potential insulin delivery route for a mechanical pancreas. Diabetes Care 3: 229–234
Rizza R, Mandarino L, Gerich J (1981) Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240: E630-E639
Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914–924
Darmaun D, Cirillo D, Koziet J, Chauvet D, Young VR, Robert JJ (1988) Whole body glucose kinetics in type I diabetes studied with (6,6-2H) and (U-13C) glucose and the artificial B-cell. Metabolism 37: 491–498
Madison LL, Unger RH (1958) The physiologic significance of the secretion of endogenous insulin into the portal circulation: comparison of the effects of glucagon-free insulin administered via the portal vein and via a peripheral vein on the magnitude of hypoglycemia and peripheral glucose utilization. J Clin Invest 37: 631–639
Poulsen JSD, Smith M, Deckert M, Deckert T (1980) Comparison of intraperitoneal, intraportal and intravenous insulin infusion. Acta Endocrinol 95: 500–504
Rizza RA, Westland RE, Hall LD et al. (1981) Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs. Mayo Clinic Proc 56: 434–438
Shoemaker WC, Mahler R, Ashmore J (1959) The effect of insulin on hepatic glucose metabolism in the anesthetized dog. Metabolism 8: 494–511
Starzl TE, Scanlan WA, Yanof HM et al. (1963) A comparison of the hypoglycemic effect of insulin with systemic venous and portal venous administration. J Surg Res 3: 293–300
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robert, J.J., Chauvet, D., Darmaun, D. et al. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in Type 1 (insulin-dependent) diabetic patients. Diabetologia 36, 1185–1190 (1993). https://doi.org/10.1007/BF00401064
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401064